Product NDC: | 63323-288 |
Proprietary Name: | Naropin |
Non Proprietary Name: | ROPIVACAINE HYDROCHLORIDE |
Active Ingredient(s): | 10 mg/mL & nbsp; ROPIVACAINE HYDROCHLORIDE |
Administration Route(s): | EPIDURAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-288 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020533 |
Marketing Category: | NDA |
Start Marketing Date: | 20110531 |
Package NDC: | 63323-288-10 |
Package Description: | 5 BLISTER PACK in 1 BOX (63323-288-10) > 1 AMPULE in 1 BLISTER PACK > 10 mL in 1 AMPULE |
NDC Code | 63323-288-10 |
Proprietary Name | Naropin |
Package Description | 5 BLISTER PACK in 1 BOX (63323-288-10) > 1 AMPULE in 1 BLISTER PACK > 10 mL in 1 AMPULE |
Product NDC | 63323-288 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ROPIVACAINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | EPIDURAL |
Start Marketing Date | 20110531 |
Marketing Category Name | NDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | ROPIVACAINE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |